>Abituzumab VH
QVQLQQSGAELAKPGASVKLSCKASGYTFTSFWMHWVKQRPGQGLEWIGYINPRSGYTEYNEIFRDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARFLGRGAMDYWGQGTSVTVSS
>Abituzumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLAWYQQKPDGTIKLLIYYTSKIHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTFPYTFGGGTKLEIK
>Afutuzumab VH
QVQLQQSGPELVKPGASVKISCKASGYAFSYSWINWVKQRPGQGLEWIGRIFPGDGDTDYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARNVFDGYWLVYWGQGTLVTVSA
>Afutuzumab VL
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK
>Alacizumab VH
EVKLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATITSGGSYTYYVDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARIGEDALDYWGQGTSVTVSS
>Alacizumab VL
DIQMTQSPSSLSASLGERVSLTCRASQDIAGSLNWLQQEPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYGSFPPTFGGGTKLEIK
>Alemtuzumab VH
DVMLVESGGGLVQPGGSLSLSCAASGFTFTDFYMNWVRQPPGKALEWLGFIRDKAKGYTTEYNPSVKGRFTILRDNSQSILYLQMNALRAEESATYYCAREGHTAAPFDYWGQGSTLTVSS
>Alemtuzumab VL
DIKLIQSQASLSASLGETVTLTCKASQNIDKYLNWYQQKQGKSPKLLVYNTNNLQTGVPSRFSGSGSGTQFSLKINSLQTEDFGNYYCLQHISRPRTFGGGTKLEIK
>Anrukinzumab VH
EVQLVESGGGLVKLGGSLKLSCAASGFTFSSYAMSWVRQTPGKRLEWVASISSGGNTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARLDGYYFGFAYWGQGTLVTVSA
>Anrukinzumab VL
DIVLTQSPASLAVSLGQRATISCKASESVDNYGKSLMHWYQQKPGQPPKLLIYRASNLESGIPARFSGSGSRTDFTLTINPVEADDIATYYCQQSNEDPWTFGGGTKLEIK
>Atezolizumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSDSWIHWIRQAPTKGLEWVAWISPYGGSTYYADSVKGRFTIFRDVAKSTLYLQMDSLRSEDTATYYCARRHWPGGFDYWGQGVMVTVSS
>Atezolizumab VL
DIVMTQSHKFMSTSVGDRVSITCRASQDVSTAVAWYQQKPGQSPKLLIYSASFLYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYLYHPATFGGGTKLEIK
>Bapineuzumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMSWVRQVPTKGLEWVTSIRSGGGRTYYSDNVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCVRYDHYSGSSDYWGQGVMVTVSS
>Bapineuzumab VL
DVVMTQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWLLQRPGQSPKRLIYLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGGGTKLEIK
>Bemarituzumab VH
QVQLQQSGAELVKPGASVKMSCKASGYTFTTYNVHWVKQTPGQGLEWIGSIYPDNGDTSYNQNFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDFAYWGQGTLVTVSA
>Bemarituzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQGVSNDVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHSTTPYTFGGGTKLEIK
>Benralizumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVIHWVKQRPGQGLEWIGYINPYNDGTKYNERFKGKATLTSDKSSSTAYMELSSLTSEDSAVYLCGREGIRYYGLLGDYWGQGTSVTVSS
>Benralizumab VL
DIQMTQTTSSLSASLGDRVTISCGTSEDIINYLNWYQQKPDGTVKLLIYHTSRLQSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGYTLPYTFGGGTKLEIK
>Bevacizumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVRQAPGKGLKWMGWINTYTGEPTYAADFKRRFAFSLETSASTAYLQINNLKNEDMATYFCARYPHYYGSSHWYFDVWGAGTTVTVSS
>Bevacizumab VL
DIQMTQTTSSLSASLGDRVTISCSASQDISNYLNWYQQKPDGTVKLLIYFTSSLHSGVPSRFSGSGSGTDYFLTISNLEPEDIATYYCQQYSTVPWTFGGGTKLEIK
>Blosozumab VH
EVQLQQSGAELVRPGASVKLSCTASGFNIKDTFQHWVKQRPEQGLEWIGWSDPEIGDTEYASKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCTTGDTTYKFDFWGQGTTLTVSS
>Blosozumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVHTAVAWYQQKPGQSPKLLIYWASTRWTGVPDRFTGSGSGTDFTLTISNLQSEDLADYFCQQYSDYPWTFGGGTKLEIK
>Bococizumab VH
QVQLKQPGAELVKPGASVKMSCKASGYTFTSYYMHWVKQRPGQGLDWIGEISPFGGRTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARERPLYASDLWGQGTSVTVSS
>Bococizumab VL
DIVMTQSHKSMSTSVGDRVSITCRASQGISSALAWYQQKPGQSPKLLIYSASYRYTGVPGRFTGSGSGTDFTFTISSVQAEDLAVYYCQQRYSLWRTFGGGTKLEIK
>Brontictuzumab VH
QVQLKQSGAELMKPGASVKLSCKATGYTFTGYWIEWVKQRPGHGLEWIGQILPGTGRTNYNEKFKGKATFTADTSSTPAYMPLSSLTTEDSAIYYCARFDGNYGYYAMDYWGQGTSVTVSS
>Brontictuzumab VL
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQQKPDQLFTGLIGGTNNRAPGVPARFSGSLIGGKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL
>Cabiralizumab VH
QVQLQQSGPELVKPGASVKIPCKASGYTFTDNYMIWVKQSHGKSLEWIGDINPYNGGTTFNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARESPYFSNLYVMDYWGQGTSVTVSS
>Cabiralizumab VL
DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDNYMNWYQQKPGQPPKLLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCHLSNEDLSTFGGGTKLEIK
>Camrelizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYMMSWVRQTPEKRLEWVATISGGGANTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTALYYCARQLYYFDYWGQGTTLTVSS
>Camrelizumab VL
DIQMTQSPASQSASLGESVTITCLASQTIGTWLTWYQQKPGKSPQLLIYTATSLADGVPSRFSGSGSGTKFSFKISSLQAEDFVSYYCQQVYSIPWTFGGGTKLEIK
>Cantuzumab VH
QIQLVQSGPELKKPGETVKISCKASDYTFTYYGMNWVKQAPGKGLKWMGWIDTTTGEPTYAQKFQGRFAFSLETSASTAYLQIKNLKNEDTATYFCARRGPYNWYFDVWGAGTTVTVSS
>Cantuzumab VL
DIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLVSGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGGGTKLELK
>Cergutuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTEFGMNWVKQAPGKGLKWMGWINTKTGEATYVEEFKGRFAFSMETSASTAYLQINNLKNEDMATYFCARWDFAYYVEAMDYWGQGTSVTVSS
>Cergutuzumab VL
DIVMTQSQQFVSTSVGDRVSVTCKASAAVGTYVAWDQQKPGQAPKALMYSASYRKRGVPDRFTGSGSGTDFTLTISNGQSEDLAEYFCHQYYTYPLFTFGSGTKLEIK
>Certolizumab VH
EVQRVESGPELKKPGETVKISCKASGYVFTDYGMNWVKQAPGKGLKWMGWINTYIGEPIYADSVKGRFAFSLETSASTAYLQINNLKNEDTATYFCARGYRSYAMDYWGQGTSVTVSS
>Certolizumab VL
DIVMTQSQTSMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKALIYSASFLYSGVPYRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNIYPLTFGAGTKLELK
>Citatuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADSFKGRFAFSLEPSASAAYLQINNLNNEDTATCFCARFAIKGDYWGQGTTLTVSS
>Citatuzumab VL
DIVMTQVASSNPVTLGTSASISCRSTKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLEIPRTFGGGTKLELK
>Clivatuzumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFPSYVLHWVKQKPGQGLEWIGYINPYNDGTQYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARGFGGSYGFAYWGQGTLVTVSA
>Clivatuzumab VL
QIVLTQSPSIMSASPGEKVTMTCSASSSVSSSYLYWYQQKPGSSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAASYFCHQWNRYPYTFGGGTKLEIK
>Codrituzumab VH
QVQLQQSGAELVRPGASVTLSCKASGYTFTDYEMHWVKQTPVHGLEWIGALDPKTGDTAYSQKFKGKAILTADKSSSTAYMELRSLTSEDSAVYYCTRFYSYTYWGQGTTLTVSS
>Codrituzumab VL
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNRNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQNTHVPPTFGGGTKLEIK
>Cofetuzumab VH
QVQLKQSGPEVVRPGVSVKISCKGSGYTFTDYAVHWVKQSHAKSLEWIGVISTYNDYTYNNQDFKGKATNTVDNSSSTDYMELARLTSEDSAINYCARGNSYFYALDYWGQGTSVTVSS
>Cofetuzumab VL
EIVLTHSPASLPVSLGLRATISCRASESVDSYGKSFMHWYQQKPGQPPKLLIYRASNLESGVPARFSGSGSRTDFTLTINRVEADDVATYYCQQSNEDPWTFGGGTKLEIK
>Concizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARLGGYDEGDAMDSWGQGTSVTVSS
>Concizumab VL
DVVMTQTPLTLSVTIGQPASISCKSSQSLLESDGKTYLNWLLQRPGESPKLLIYLVSILDSGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCLQATHFPQTFGGGTKLEIK
>Crenezumab VH
EVELVESGGGLVQPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLELVASINSNGGSTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCASGDYWGQGTTLTVSS
>Crenezumab VL
DIVMTQSPLSLPVSLGDQASISCRSSQSLVYSNGDTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIK
>Crizanlizumab VH
QVQLQQSGPELVKPGALVKISCKASGYTFTSYDINWVKQRPGQGLEWIGWIYPGDGSIKYNEKFKGKATLTADKSSSTAYMQLSSLTSENSAVYFCARRGEYGNYEGAMDYWGQGTSVTVSS
>Crizanlizumab VL
DIVMTQSPASLAVSLGQRATISCKASQSVDYDGHSYMNWYQQKPGQPPKLLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSDENPLTFGGGTKLEIK
>Dacetuzumab VH
EVQGVESGPDLVKPGASVKISCKASGYSFTGYYIHWVKQSHGKSLEWIGRVIPNAGGTSYNQKFKGKAILTVDKSSSTAYMELRSLTSEDSAVYYCAREGIYWWGQGTTLTVSS
>Dacetuzumab VL
DIVMTQTPLSLSVSLGDQVSISCRSSQSLVHSNGNTFLHWYLQKPGQSPKLLIYTVSNRFSGVPDSFSGSGSGTDFTLKISRVETEDLGVYFCSQTTHVPWTFGGGTKLEIK
>Daclizumab VH
QVQLQQSGAELAKPGASVKMSCKASGYTFTSYRMHWVKQRPGQGLEWIGYINPSTGYTEYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGGGVFDYWGQGTTLTVSS
>Daclizumab VL
QIVLTQSPAIMSASPGEKVTMTCSASSSISYMHWYQQKPGTSPKRWIYTTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSTYPLTFGAGTKLEVK
>Dalotuzumab VH
QVQLQQSGPGLVKPSQSLSLTCSVTGYSITGGYLWNWIRQFPGNKLEWMGYISYDGTNNYKPSLKDRISITRDTSKNQFFLKLNSVTTEDTATYYCARYGRVFFDYWGQGTTLTVSS
>Dalotuzumab VL
DIVMTQSPLSLPVSLGDQASISCRSSQSIVHSNGNTYLQWYLQKPGQSPKLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPWTFGGGTKLEIK
>Dapirolizumab VH
QVQLKESGPGLVQSSQTLSLTCTVSGFSSTNYHVHWVRQPPGKGLEWMGVIWGDGDTSYNSVLKSRLSISNDTSKSQVFLKMNSLQTEDTATYYCARQLTHYYVLAAWGQGASVTVSS
>Dapirolizumab VL
DIQMTQTTSSMSASLGDRVTISCRASEDLYYNLAWYQRKPGRSVKLLIYDTYRLADGVPSRFSGSGSGADYSLTISSLEPEDVASYYCQQYYKFPFTFGAGTKLEIK
>Demcizumab VH
QVQLQQSGPELVKTGASVKISCKASGYSFTAYYIHWVKQSHGKSLEWIGYISSYNGATNYNQKFKGKATFTVDTSSSTAYMELSSLTSEDSAVYYCARDYDYDVGMDYWGQGTSVTVSS
>Demcizumab VL
DIVLTQSPASLAVSLGQRATISCRASESVDNYGISFMKWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSKEVPWTFGGGTKLEIK
>Denintuzumab VH
QVQLQQSGPGILQPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKRYNPALKSRLTISKDTSSNQVFLKIASVDTADTATYYCARMELWSYYFDYWGQGTTLTVSS
>Denintuzumab VL
EIVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDVATYYCFQGSVYPFTFGSGTKLEIK
>Dezamizumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTTYNMHWVKQTPGQGLEWIGYIYPGDGNANYNQQFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDFDYDGGYYFDSWGQGTTLTVSS
>Dezamizumab VL
DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVHNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGAPLTFGAGTKLELK
>Domagrozumab VH
EVKLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTSYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCAKQDYAMNYWGQGTSVTVSS
>Domagrozumab VL
DIVMTQSPKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPWTFGGGTKLEIK
>Duligotuzumab VH
EVMLVESGGGLVQPGGSLRLSCAASGFTFSGDWIHWVRQTPEKRLEWVAEISAAGGYTDYADSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARESRVSFEAAMDYWGQGTSVTVSS
>Duligotuzumab VL
DIVMTQSQKFMSTSVGDRVSVTCRASQNIATDVAWYQQKPGQSPKALIYSASFLYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQSEPEPYTFGGGTKLEIK
>Eculizumab VH
QVQLQQSGAELMKPGASVKISCKATGYTFSNYWIQWVKQRPGHGLEWIGEILPGSGSTEYTENFKDKATFTADTSSNTAYMQLSSLTSEDSAVYYCARYFFGSSPNWYFDVWGAGTTVTVSS
>Eculizumab VL
DIQMTQSPASLSASVGETVTITCGASENIYGALNWYQRKQGKSPQLLIYGATNLADGMSSRFSGSGSGRQYSLKISSLHPDDVATYYCQNVLNTPLTFGAGTKLELK
>Efalizumab VH
QVQLQQSGAELVRPGASVKLSCKASGYSFTGHWMNWVKQRPGQGLEWIGMIHPSDSETRYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCARGIYFYGTTYFDYWGQGTTLTVSS
>Efalizumab VL
DVQITQSPSYLAASPGETITINCRASKTISKYLAWYQEKPGKTNKLLIYSGSTLQSGIPSRFSGSGSGTDFTLTISSLEPEDFAMYYCQQHNEYPLTFGAGTKLELK
>Elotuzumab VH
EVQLVESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCARPDGNYWYFDVWGAGTTVTVSS
>Elotuzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVGIAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYPYTFGGGTKLEIK
>Emactuzumab VH
QVQLQQSGAELVKPGASVKMSCKASGYTFTSYDISWVKQRPGQGLEWIGVIWTDGGTNYAQKLQGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARDQRLYFDVWGTGTTVTVSS
>Emactuzumab VL
NIVMIQSPKSMSMSVGERVTLSCRASEDVNTYVSWYQQKPEQSPQLLIYAASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCQQSFSYPTFGGGTKLEIK
>Emibetuzumab VH
QVQLQQSGPELVKPGASVKISCKASGYTFTDYYMHWVKQSHGKSLEWIGRVNPNRRGTTYNQKFEGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARANWLDYWGQGTTLTVSS
>Emibetuzumab VL
ENVLTQSPAIMSASPGEKVTMTCSVSSSVSSIYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQVYSGYPLTFGGGTKLEIK
>Emicizumab VH
QVQLQQSGPELVKPGASVKIPCKASGYTFTDNNMDWVKQSPGKSLEWIGDINTRSGGSIYNEEFQDKATLTVDKSSSTAYMELRSLTSEDTAVYHCARRKSYGYYLDEWGEGTTVTVSS
>Emicizumab VL
DIQMNQSPSSLSASLGDTITITCKASRNIERQLAWYQQKPGQSPKLLIYQASRKESGVPDRFTGSRYGTDFTLTISNVQSEDLADYFCQQYSDPPLTFGAGTKLELK
>Enavatuzumab VH
EVQVVESGGGLVQPGGSMKLSCVASGFTFSSYWMSWVRQSPEKGLEWVAEIRLKSDNYATHYAESVKGKFTISRDDSKSRLYLQMNSLRAEDTGVYYCTTYYADAMDYWGQGTSVTVSS
>Enavatuzumab VL
DIVLTQSPASLAVSLGQRVTISCRASQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVEEEDTATYYCQHSWEIPYTFGGGTKLEIK
>Enoblituzumab VH
EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSDSSAIYYADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCGRGRENIYYGSRLDYWGQGTSVTVSS
>Enoblituzumab VL
DIVMTQSQKFMSTSVGDRVSVTCKASQNVDTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNNYPFTFGSGTKLEIK
>Enokizumab VH
QVQLQQSGAELMKPGASVKISCKATGYTFSYYWIEWVKQRPGHGLEWIGEILPGSGTTNPNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARADYYGSDYVKFDYWGQGTTLTVSS
>Enokizumab VL
DIVMTQSQIFMSTSVGDRVTVTCKASQHVITHVTWYQQKPGQSPKALIYGTSYSYSGVPNRFTGSGSGTDFTLTISNVQSEDLAEYFCQQFYEYPLTFGAGTKLELK
>Epratuzumab VH
QVQLQQSGAELVRPGTSVKLSCKASGYTFTSYWLHWVKQRPGQGLEWIGYINPRNDYTEYNQNFKDKATLTVDTSSSTAYMQLSSLTSEDSAFYYCARRDITTFYWGQGTTLTVSS
>Epratuzumab VL
NIMMTQSPSSLAVSVGERVTMSCKSSQSVLYSANHKNYLAWYQQKPGQSTKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCHQYLSSWTFGGGTKLEIK
>Etaracizumab VH
EVQRVESGGGLVKPGGSLKLSCAASGFAFSSYDMSWVRQTPEKRLEWVAKVSSGGGSTYYLDTVQGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHLHGSFASWGQGTLVTVSA
>Etaracizumab VL
DIVLTQSTATLSVTPGDRVSLSCQASQSISNFLHWYHQKSGESPRLLIRYRSQSISGIPSRFSGSGSGTDFTLTINSVETEDFGVYFCQQSGSWPLTFGGGTKLELK
>Farletuzumab VH
EVQLVESGGDLVKPGGSLKLSCAASGFTFSGYGLSWVRQTPDKRLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLYLQMSSLKSEDTAMYYCARHGDDPAWFAYWGQGTPVTVSA
>Farletuzumab VL
EIVLTQSPALMAASPGEKVTITCSVSSSISSNNLHWYQQKSETSPKPWIYGTSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSYPYMYTFGGGTKLEIK
>Fibatuzumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTGYWMNWVKQRPGQGLEWIGDIYPGSGNTNYDEKFQGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYEDFDSWGQGTTLTVSS
>Fibatuzumab VL
DIQMTQSPSSLSASLGERVSLTCRASQGIISYLAWLQQKPEGTIKRLIYAASSLQSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCGQYANYPYTFGGGTKLEIK
>Ficlatuzumab VH
QVQLQQPGTELVKPGTSVKLSCKASGYTFTTYWMHWVKQRPGQGLEWIGEINPTNGHTNYNQKFQGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARNYVGSIFDYWGQGTTLTVSS
>Ficlatuzumab VL
NIVMTQSPKSMSMSVGERVTLSCKASENVVSYVSWYQQKTEQSPKLVIYGASNRESGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQSYNYPYTFGGGTKLEIK
>Flotetuzumab VH
EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMKWVKQSHGKSLEWIGDIIPSNGATFYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARSHLLRASWFAYWGQGTLVTVSA
>Flotetuzumab VL
DFVMTQSPSSLAVSAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPYTFGGGTKLEIK
>Fontolizumab VH
QVQLKQPGAELVRPGSSVKLSCKASGYTFTSSWINWVKQRPIQGLEWIGRIDPSDGEVHYNQDFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGFLPWFADWGQGTLVTVSA
>Fontolizumab VL
NIVMTQSPKSMSMSIGERVTLSCKASENVDTYVSWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQSYNYPFTFGSGTKLEVK
>Fremanezumab VH
EVKLVESGGGLVQPGGSMKLSCVASGFTFSNYWISWVRQSPEKGLEWVAEIRSESDASATHYAEAVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCLAYFDYGLAIQNYWGQGTLVTVSA
>Fremanezumab VL
EIVMTQSPKSMSMSVGERDSLICKASKRVTTYVSWYQQKPEQSPKLLIYGASNRYLGVPDRFTGSGSATYFTLTISSVQAEDLADYHCSQSYNYPYTFGAGTKLEIK
>Galcanezumab VH
QVQLQQSGAELVRPGTSVKMSCKASGYTFTNYWMQWAKQRPGHGLEWIGAIYEGTGKTVYIQKFADKATLTADKSSSTAYMQFSSLTSEDSAIYYCARLSDYVSGFGYWGQGTTLTVSS
>Galcanezumab VL
DIQMTQTTSSLSASVGDRVTISCRASKDISKYLNWYQQKPDGTVKLLIYYTSGYHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGDALPPTFGGGTKLEIK
>Gatipotuzumab VH
EVQLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRLKSNNYTTHYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTRHYYFDYWGQGTTLTVSS
>Gatipotuzumab VL
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGGGTKLEIK
>Gemtuzumab VH
EVQLQQSGPELVKPGASVKISCKASGYTFTDSNIHWVKQSPGKSLEWIGYIYPYNGGTDYNQKFKNKATLTVDNPSSTAYMELRSLTSEDSAFYYCANGNPWLAYWGQGTLVTVSA
>Gemtuzumab VL
DIVLTQSPATLAVSLGQRATISCRASESLDNYGIRFLTWFQQKPGQPPKLLMYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQTKEVPWSFGGGTKLEVK
>Gevokizumab VH
QVTLKESGPGILKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARNRYDPPWFVDWGQGTLVTVSA
>Gevokizumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLSWYQQKPDGTVKLLIYYTSKLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCLQGKMLPWTFGGGTKLEIK
>Ibalizumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVIHWVKQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCAREKDNYATGAWFAYWGQGTLVTVSA
>Ibalizumab VL
DIVMTQSPSSLAVSVGEKVTMSCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYRTFGGGTKLEIK
>Idarucizumab VH
QVQLQQSGPGLVAPSQSLSITCTVSGFSLTSYIVDWVRQSPGKGLEWLGVIWAGGSTGYNSALRSRLSISKDNSKSQVYLKMNSLQTDDTAMYYCASAAYYSYYNYDGFAYWGQGTLVTVSA
>Idarucizumab VL
DVVMTQTPLTLSVTIGQPASISCKSSQSLLYTDGKTYLYWLLQRPGQSPKRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCLQSTHFPHTFGGGTKLEIK
>Ifabotuzumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTGYWMNWVKQRPGQGLEWIGDIYPGSGNTNYDEKFQGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYEDFDSWGQGTTLTVSS
>Ifabotuzumab VL
DIQMTQSPSSLSASLGERVSLTCRASQGIISYLAWLQQKPEGTIKRLIYAASSLQSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCGQYANYPYTFGGGTKLEIK
>Iladatuzumab VH
QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGGGDTNYNEIFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCARRVPIRLDYWGQGTLVTVSA
>Iladatuzumab VL
DIVMTQSPASLAVSLGQRATISCKASQSVDYEGDSFLNWFQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
>Imgatuzumab VH
QVQLQQSGAELAKPGASVKLSCKASGYTFTDYKIHWVKQRPGQGLEWIGYFNPNSGYSTYAQKFQGKATLTADKSSSTAYMQLSSLTYEDSAVYYCARLSPGGYYVMDAWGQGTSVTVSS
>Imgatuzumab VL
DIKMHQSPPSLYPSLGARVTITCRASQGINNYLNWYQQKPGESPKTLIYNTNNLQTGVPSRFSGSGSGQDYSLTISNLEYEDMGIYYCLQHNSFPTFGGGTKLELK
>Inebilizumab VH
EVQLQESGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNVKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARSGFITTVRDFDYWGQGTTLTVSS
>Inebilizumab VL
DIVLTQSPASQAVSLKQKATISCRASESVDTFGISFMNWFQQKPDQPPKLLIHEASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDAAMYFCQQSKEVPFTFGSGTKLEIK
>Inotuzumab VH
EVQLQQSGTVLARPGASVKMSCKASGYRFTNYWIHWVKQRPGQGLEWIGGINPGNNYATYRRKFQGKAKLTAVTSTSTAYMELSSLTNEDSAVYYCTREGYGNYGAWFAYWGQGTLVTVSA
>Inotuzumab VL
DVVVTQTPLSLSVSFGDQVSISCRSSQSLANSYGNTFLSWYLHKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISTIKPEDLGMYYCLQGTHQPYTFGSGTKLEIK
>Itolizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQTPEKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTTLTVSS
>Itolizumab VL
DIKMTQSPSSTYASLGARVTITCKASRDIRSYLTWYQQKPWKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK
>Ixekizumab VH
QVQLQQSGPELVKPGASVKISCKASGYSFTDYHIHWVKQSPGKGLEWIGVINPMYGTTDYNQRFKGKATLTVDQSSSTAYMQLNSLTSEDSAVYYCARYDYFTGTGVYWGQGTLVTVSA
>Ixekizumab VL
DIVLTQSTLSLPVSLGDQASISCRSSRSLVHSRGNTYLHWYLQKPGQSPKLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHLPFTFGSGTKLEIK
>Labetuzumab VH
EVQLQESGGGLVQPGGSLKLSCAASGFDFSTYWMSWVRQAPGKGLEWIGEIHPDSSTINYAPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCATLYFGFPWFAYWGQGTPVTVSA
>Labetuzumab VL
DIVMTQSPKFMSTSVGDRVSITCKASQDVGTSVAWYQQKPGQSPKLLIYWTSTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSLYRSFGGGTKLEIK
>Lacnotuzumab VH
EVQLQESGPGLVKPSQSLSLTCTVTDYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARFDYAHAMDYWGQGTSVTVSS
>Lacnotuzumab VL
DILLTQSPAILSVSPGEKVSFSCQASQSIGTSIHWYQQKTDGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDAADYYCQQINSWPTTFGGGTKLEIK
>Ladiratuzumab VH
EVQLQQSGAELVKPGASVKLSCTASGLNIEDYYMHWVKQRPEQGLEWIGWIDPENGDTEYGPKFQGKATMTADTSSNTAYLQLSSLTSEDTAVYYCNVHNAHYGTWFAYWGQGTLVTVSA
>Ladiratuzumab VL
DVLMTQTPPSLPVSLGDQASISCRSSQSLLHSSGNTYLEWYLQKPGQSPKPLIYKISTRFSGVPDRFSGSGSGTDFTLKISSVEAEDLGVYYCFQGSHVPYTFGGGTKLEIK
>Lambrolizumab VH
QVQLQQSGVELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGGINPSNGGTNFNEKFKNKATPTVDSSSSTAYMQLKSLQFEDSAVYFCARRDYRFDMGFDYWGQGTTLTVSS
>Lambrolizumab VL
DIVLTQSPASLAVSLGQRATISCRASKGVSTSGYSYLHWYQQKPGQPPKLLIYLASYLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRDLPLTFGGGTKLEIK
>Lampalizumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGETTYADDFKGRFVFSLDTSVSTAYLQINNLKNEDMATYSCEREGGVNNWGQGTMVTVSA
>Lampalizumab VL
ETTVTQSPASLSMAIGEKVTIRCITSTDIDDDMNWYQQKPGEPPKLLISGGNTLRPGVPSRFSSSGYGTDFVFTIENMLSEDVADYYCLQSDSLPYTFGGGTKLEIK
>Landogrozumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSRYPMSWVRQAPKKGLEWVAAITSSGGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRSEDTATYYCARLPDYWGQGTLVTVSS
>Landogrozumab VL
ENVLTQSPAIMSASPGEKVTMTCRASSSVSSSYLHWYQQKSGASPKLWIYSTSNLVAGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQHHSGYHFTFGSGTKLEIK
>Lebrikizumab VH
QVQLRESGPGLVAPSQSLSITCTVSGFSLTAYSVNWVRQPPGKGLEWLGMIWGDGKIVYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARDGYYPYAMDNWGQGSSVTVSS
>Lebrikizumab VL
DIVMTQSPASLAVSLGQRATISCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPRTFGGGTKLEIK
>Lifastuzumab VH
EVQLVESGGGVVQPGKSLKLSCAASGFSFSDFAMSWVRQSPKMGLEWVATIGRVAFHTYYPDSMKGRFIISRDNAKNTLYLQMDSLRSEETATYYCARHRGFDVGHFDFWGPGTMVTVSS
>Lifastuzumab VL
DIQMTQTPLSLPVSLGDQAAISCRSSETLVHSSGNTYLEWYLQKPGQSPKLLIYRVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSFNPLTFGAGTKLELK
>Ligelizumab VH
QVQLQQPGAELMRPGSSVKLSCKASGYTFTWYWLEWVKQRPIHGLEWIGEIDPGTFTTNYNEKFKAKATFTVDKSSSTAYMQLSSLTSEDSAVYYCARFSHFSGSNYDYFDYWGQGTTLTVSS
>Ligelizumab VL
DILLTQSPAILSVSPGERVSFSCRASQSIGTNIHWYQQKTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQSWSWPTTFGGGTKLEIK
>Lintuzumab VH
QVQLQQSGAELVKPGASVKISCKASGYTFTDYNMHWVKQSHGKSLEWIGYIYPYNGGTGYNQKFKSKATLTVDNSSSTAYMELRSLTSEDSAVYYCARGRPAMDYWGQGTSVTVSS
>Lintuzumab VL
DIVLTQSPASLAVSVGQRATITCRASESVDNYGISFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQSKEVPWTFGGGTKLEIK
>Lorvotuzumab VH
EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSGSFTIYYADSVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCARMRKGYAMDYWGQGTSVTVSS
>Lorvotuzumab VL
DVVMTQTPLSLPVSLGDQASISCRSSQIIIHSDGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPHTFGGGTKLEIK
>Lumretuzumab VH
QVQLQQSGAELVKPGASVKLSCKTSGFTFSSSYISWLKQKPGQSLEWIAWIYAGTGSPSYNQKLQGKAQLTVDTSSSTAYMQFSSLTTEDSAIYYCARHRDYYSNSLTYWGQGTTLTVSS
>Lumretuzumab VL
DIVMTQSPSSLTVTAGEKVTMSCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQSDYSYPYTFGGGTKLEIK
>Lutikizumab VH
EVKLQESGGGLVKPGGSLKLSCAASGFTFSRYDMSWVRQTPEKRLEGVAYISHGGAGTYYPDSVKGRFTISRDNAKNNLYLQMSHLKSEDTAMYYCARGGVTKGYFDVWGTGTPVTVSS
>Lutikizumab VL
DIQMTQSPASLSASVGETVTITCRASGNIHNYLTWYQQTQGKSPQLLIYNAKTLADGVPSRFSGSGSGTQYSLKINSLQPEDFGIYYCQHFWSIPYTFGGGTKLQIT
>Matuzumab VH
QVQLQQSGAELVKPGASVKLSCKASGYTFTSHWMHWVKQRPGQGLEWIGEFNPSNGRTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCASRDYDYDGRYFDYWGAGTTVTVSS
>Matuzumab VL
DIVLTQSPAILSASPGEKVTMTCSASSSVTYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSHIFTFGSGTKLEIK
>Mepolizumab VH
QVQLRESGPGLVAPSQSLSITCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDNSKSQVCLKMNSLQIDDPAMYYCARDPPSSLLRLDYWGQGTPVTVSS
>Mepolizumab VL
DIVMTQSPSSLSVSAGEKVTMSCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNVHSFPFTFGSGTKLEIK
>Milatuzumab VH
QLQLVQSGPELKKPGETVKISCKASGYTFTNYGVNWVKQAPGKGLQWMGWINPNTGEPTFDDDFKGRFAFSLETSVSTAYLQLTNLKNEDTATYFCSRSRGKNEAWFAYWGQGTLVTVSA
>Milatuzumab VL
DIVLTQSPLSLPVSLGDQASISCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSSHVPPTFGAGTKLEIK
>Mirikizumab VH
QVQLKQSGPELVKPGASVKVSCKASGYKFTRYVMHWVKQKPGQGLEWIGYINPYNDGTNYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARNWDTGLWGQGTLVTVSA
>Mirikizumab VL
DIQMTQSPSSLSASLGGRVTITCKASDHILKFLTWYQQKPGNAPRLLISGATSLETGVPSRFSGSGSGKDYTLSITSLQTEDVATYYCQMYWSTPFTFGSGTKLEIK
>Mogamulizumab VH
EVQLVESGGDLVKPGGSLKLSCAASGFTFSNYGMSWVRQTPDKRLEWVATISSASTYSYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCGRHSDGNFAFGYWGQGTTLTVSS
>Mogamulizumab VL
DVLMTQTPLSLPVSLGDQASISCRSSRNIVHINGDTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSLLPWTFGGGTKLEIK
>Monalizumab VH
QVQLQQSGAELVRPGSSVKLSCKASGYTFTSYWMNWVKQRPIQGLEWIGRIDPYDSETHYAQKLQGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGGYDFDVGTLYWFFDVWGTGTTVTVSS
>Monalizumab VL
DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLIYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPRTFGGGTKLEIK
>Mosunetuzumab VH
QVQLQQSGAELVRPGASVKLSCKASGYTFTNYYIHWVKQRPGQGLEWIAWIYPGDGNTKYNEKFKGKATLTAEKSSSTAYMQLSSLTSEDSAVYFCARDSYSNYYFDYWGQGTTLTVSS
>Mosunetuzumab VL
DIVMTQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCTQSFILRTFGGGTKLEIK
>Motavizumab VH
QVTLRVSGPGILQPSQTLSLTCSFSGFSLSTAGMSVGWIRQPSGKGLEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVFLKIANGDTADTATYYCARDMIFNFYFDVWGTGTTVTVSS
>Motavizumab VL
DIVMTQSPAIMSASPGEKVTITCSASSRVGYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCFQGSGYPFTFGSGTKLEIK
>Natalizumab VH
QVQLQQSGAELVKPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIDPANGYTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAIYYCAREGYYGNYGVYAMDYWGQGTSVTVSS
>Natalizumab VL
DIQMTQSPSSLSASLGGKVTITCKTSQDINKYMAWYQHTPGKGPRLLIHYTSALQPGIPSRFSGSGSGRDYSFSISNLEPEDIATYYCLQYDNLWTFGGGTKLEIK
>Nemolizumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTGYIMNWVKQKPGQGLEWIGLINPYNGGTDYNPQFQDKATLTSDKSSSTAYMELSSLTSEDSAVYDCARDGYDDGPYTLETWGQGTTLTVSS
>Nemolizumab VL
DIQMTKSPASLSASVGETVTITCQASEDIYSFVAWYQQKQGKSPQLLVYNAQTEAQGVPSRFSGSGSGTQFSLKISSLQPEDFGSYYCQHHYDSPLTFGAGTKLELK
>Nimotuzumab VH
QVQLQQSGAELVKPGASVKLSCKASGYTFTNYYIYWVKQRPGQGLEWIGGINPTSGGSNFNEKFKTKATLTVDKSSSTAYMQLSSLTSEDSAFYYCTRQGLWFDSDGRGFDFWGQGTTLTVSS
>Nimotuzumab VL
DVLMTQTPLSLPVSLGDQASISCRSSQNIVHSNGNTYLDWYLQTPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQYSHVPWTFGGGTKLQIT
>Obinutuzumab VH
QVQLQQSGPELVKPGASVKISCKASGYAFSYSWINWVKQRPGQGLEWIGRIFPGDGDTDYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARNVFDGYWLVYWGQGTLVTVSA
>Obinutuzumab VL
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK
>Ocaratuzumab VH
QVQLQQSGAELVRPGASVKMSCKASGRTFTSYNMHWVKQTPRQGLEWIGAIYPLTGDTSYNQKSKLKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARSTYVGGDWQFDVWGTGTTVTVSS
>Ocaratuzumab VL
QIVLSQSPAILSASPGEKATMTCRASSSVPYIHWYQQKPGSSPKPWIYATSALASGIPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWLSNPPTFGGGTKLEIK
>Ocrelizumab VH
QVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSS
>Ocrelizumab VL
QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSFNPPTFGGGTKLEIK
>Olendalizumab VH
QVQLQQSGPELVKPGASVKISCKASGYTFTDYSMDWVKQSHGKSLEWIGAIHLNTGYTNYNQKFKGKATLNVDKSSSTAYMELRSLTSEDSAVYYCARGFYDGYSPMDYWGQGTSVTVSS
>Olendalizumab VL
DIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFMHWYQQKPGQPPKLLIYRASNLESGVPARFSGSGSRTDFTLTISPVEADDVATYYCQQSNEDPYTFGGGTKLEIK
>Omalizumab VH
EVQLQESGPGLVKPSQSLSLTCSVTGYSITSGYSWNWIRQFPGNKLEWMGSITYDGSTNYNPSVKGRISITRDTSKNQFFLKLNSVTTEDTATYYCARGSHYFGHWHFAVWGTGTTVTVSS
>Omalizumab VL
DIVLTQSPASLAVSLGQRATISCRASQSVDYDGDSYMNWYQQKPGQAPKLLIYAASYLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSHEDPYTFGGGTKLEIK
>Onartuzumab VH
QVQLQQSGPELVRPGASVKMSCTASGYTFTSYWLHWVKQRPGQGLEWIGMIDPSNSDTRFNPNFKDKATLNVDKSSNTAYMQLSSLTSEDSAVYYCATYRSYVTPLDYWGQGTTLTVSS
>Onartuzumab VL
DIVMSQSPSSLAVSVGEKVTMSCKSSQSLLYTSSQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQQYYAYPWTFGGGTKLEIK
>Oportuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADSFKGRFAFSLEPSASAAYLQINNLNNEDTATCFCARFAIKGDYWGQGTTLTVSS
>Oportuzumab VL
DIVMTQVASSNPVTLGTSASISCRSTKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLEIPRTFGGGTKLELK
>Otlertuzumab VH
EVQLQQSGPELEKPGASVKISCKASGYSFTGYNMNWVKQSNGKSLEWIGNIDPYYGGTTYNRKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCARSVGPFDSWGQGTTLTVSS
>Otlertuzumab VL
DIQMTQSPASLSASVGETVTITCRASENVYSYLAWYQQKQGKSPQLLVYFAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHSDNPWTFGGGTKLEIK
>Ozanezumab VH
QVQLQQSGTELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNINPSNGGTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCELMQGYWGQGTTLTVSS
>Ozanezumab VL
DIVITQDELSNPVTSGESVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGSGSGTDFTLEISRVKAEDVGVYYCQQLVEYPLTFGAGTKLELK
>Palivizumab VH
QVTLRVSGPGLLKPSQTLSLTCSFSGFSLSTSGMSVGWIRQPSGKGLEWLADIWWDDKKDYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARSMITNWYFDVWGAGTTVTVSS
>Palivizumab VL
DIVLTQTPAIMSASPGEKVTMTCKCQLSVGYMHWYQQKSSTSPKLWIYDTSKLASGVPGRFSGSGSGNSYSLTISSMEAEDVATYYCFQGSGYPFTFGSGTKLEIK
>Parsatuzumab VH
EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINLDNSGTHYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAREGVYHDYDDYAMDYWGQGTSVTGSS
>Parsatuzumab VL
DVVMTQTPLSLPVSLGDQASISCRTSQSLVHINAITYLHWYLQKPGQSPKLLIYRVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCGQSTHVPLTFGAGTKLELK
>Pateclizumab VH
EVQLKESGPELVKPGASVKMSCKASGYTFTSYVIHWVKQKPGQGLEWIGYNNPYNAGTNYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCSRPTMLPWFAYWGQGTLVTVSA
>Pateclizumab VL
DIVITQSHKFMSTSVGDRVSITCRASQAVSSAVAWYQQKPGQSPKLLIYSASHRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQESYSTPWTFGGGTKLEIK
>Pembrolizumab VH
QVQLQQSGVELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGGINPSNGGTNFNEKFKNKATPTVDSSSSTAYMQLKSLQFEDSAVYFCARRDYRFDMGFDYWGQGTTLTVSS
>Pembrolizumab VL
DIVLTQSPASLAVSLGQRATISCRASKGVSTSGYSYLHWYQQKPGQPPKLLIYLASYLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRDLPLTFGGGTKLEIK
>Perakizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSDYTMLWVRQTPEKRLEWVAIIKSGGSYSYYPDSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARDGDYGSSYGAMDYWGQGTSVTVSS
>Perakizumab VL
DIKMTQSPSSMYASLGERVTITCRASQDINSYLSWFQQKPGKSPKTLIVRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDRGIYYCLQYDAFPPYTFGGGTKLEIK
>Pertuzumab VH
EVQLQESGPELVKPGASVKIPCKASGYTFTDYTMDWVKQSHGKSLEWIGDVNPNSGGSIYNQRFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARNLGPSFYFDYWGQGTTLTVSS
>Pertuzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVSIGVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQYYIYPYTFGGGTKLEIK
>Pidilizumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLQWMGWINTDSGESTYAEEFKGRFVFSLETSVSTAYLQINNLKNEDTATYFCVRVGYDALDYWGQGTSVTVSS
>Pidilizumab VL
QIVLTQSPAIMSASPGEMVTITCSARSSVSYMHWFQQKPGTSPKLWIYRTSNLASGVPARFSGSGSGTSYCLTISRMEAEDAATYYCQQRSSFPLTFGAGTKLELK
>Pinatuzumab VH
EVQLQESGPELVKPGASVKISCKASGYEFSRSWMNWVKQRPGKGLEWIGRIYPGDGDTNYSGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARDGSSWDWYFDVWGTGTTVTVSS
>Pinatuzumab VL
DVLMTQTPLSLPISLGDQASISCRSSQSIVHSVGNTFLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSQFPYTFGGGTKLEIK
>Pogalizumab VH
ELQLKESGPELVEPGASMKMSCKASGYTFTDSYMSGVRQSHGKSLEWIGDMYPDNGDSSYNQKFREKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVLAPRWYFSVWGAGTTVTVSS
>Pogalizumab VL
DIQMTQTPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLRSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGHTLPPTFGGGTKLEIK
>Polatuzumab VH
QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGGGDTNYNEIFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCARRVPIRLDYWGQGTLVTVSA
>Polatuzumab VL
DIVMTQSPASLAVSLGQRATISCKASQSVDYEGDSFLNWFQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
>Prasinezumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMSWVRQTPTKGLEWVASISSGGGSTYYPDNVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCARGGAGIDYWGQGTLVTVSS
>Prasinezumab VL
DIVMSQSPSSLAVSVREKVTMSCKSIQTLLYSSNQKNYLAWYQQKPGQSPKLLIYWASIRKSGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPLTFGAGTKLELK
>Quilizumab VH
EVQLVESGGGLVQPGGSLKLSCAASGFTFSDYGIAWVRQAPRKGPEWVAFISDLAYTIYYADTVTGRFTISRENAKNTLYLEMSSLRSEDTAMYYCARDNWDAMDYWGQGTSVTVSS
>Quilizumab VL
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHNNANTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCSQNTLVPWTFGGGTKLEIK
>Ralpancizumab VH
QVQLQQSGAELVKPGASVKLSCKASGYTFTSYYMHWVKQRPGQGLEWIGEIHPSGGRTNYNEKFKSKATMTVDKSSSTAYMQLSSLTSEDSAVYYCARERPLYASDLWGQGTSVTVSS
>Ralpancizumab VL
DIVMTQSHKSMSTSVGDRVSITCKASQDVHTAVAWYQQKPGQSPKLLIYHASYRYTGVPGRFTGSGSGTDFTFTISSVQAEDLAVYYCQQRYSLWRTFGGGTKLEIK
>Ranibizumab VH
QIQLVQSGPELKKPGETVKISCKASGYDFTHYGMNWVRQAPGKGLKWMGWINTYTGEPTYAADFKRRFAFSLETSASTAYLQINNLKNEDMATYFCARYPYYYGTSHWYFDVWGAGTTVTVSS
>Ranibizumab VL
DIQMTQTTSSLSASLGDRVTISCSASQDISNYLNWYQQKPDGTVKLLIYFTSSLHSGVPSRFSGSGSGTDYFLTISNLEPEDIATYYCQQYSTVPWTFGGGTKLEIK
>Ravulizumab VH
QVQLQQSGAELMKPGASVKISCKATGHTFSNYWIQWVKQRPGHGLEWIGEILPGSGHTEYTENFKDKATFTADTSSNTAYMQLSSLTSEDSAVYYCARYFFGSSPNWYFDVWGAGTTVTVSS
>Ravulizumab VL
DIQMTQSPASLSASVGETVTITCGASENIYGALNWYQRKQGKSPQLLIYGATNLADGMSSRFSGSGSGRQYSLKISSLHPDDVATYYCQNVLNTPLTFGAGTKLELK
>Refanezumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFTGRFVFSLETSVSTAYLQINNLKNEDTATYFCARNPINYYGINYEGYVMDYWGQGTSVTVSS
>Refanezumab VL
NIMMTQSPSSLAVSAGEKVTISCKSSHSVLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCHQYLSSLTFGAGTKLELK
>Reslizumab VH
QVQLKESGPGLVQPSQTLSLTCTVSGLSLTSNSVNWIRQPPGKGLEWMGLIWSNGDTDYNSAIKSRLVISRDTSKSQVFLKMNSLQAEDTAMYFCAREYYGYFDYWGQGVMVTVSS
>Reslizumab VL
DIVLTQSPSSMYSSLGERVTITCLASEGISSYLAWFQQKPGKSPKTLISGANSLQTGVPSRFSGSGSAQDYSLTISSLDYEDVGIYYCQQSYKFPNTFGGGTKLEVK
>Risankizumab VH
QVQLQQSDAELVKPGASVKISCKVSGYTFTDQTIHWMKQRPEQGLEWIGYIYPRDDSPKYNENFKGKATLTADKSSSTAYMQLNSLTSEDYAVYFCAIPDRSGYAWFIYWGQGTLVTVSA
>Risankizumab VL
DIVMTQSHKFMSTSVGDRVSITCKASRDVAIAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSRTDFTLTISNVQSEDLADYFCHQYSSYPFTFGSGTKLEIK
>Rivabazumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYPMHWVRQAPTKGLEWVAVISYDGSEKWYADSVKGRFTISRDNAKSTLYLQMNSLRSEDTATYYCTRNRGDIYYDFTYAMDIWGQGASVTVSS
>Rivabazumab VL
DIQMTQSPASLSVSVGETVTITCRASEGVDRWLAWYQQKQGRSPQLLIYDASTLQSGVPSRFSGSGSGTQYSLKINSLQSEDLGSYYCQHFWGTPYTFGGGTKLEIK
>Romosozumab VH
EVQLQQSGPELVKPGASVKIPCKASGYTFTDYNMHWVKQSHGKSLEWIGEINPNSGGAGYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYYARLGYDDIYDDWYFDVWGTGTTVTVSS
>Romosozumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLLSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGDTLPYTFGGGTKLEIK
>Rontalizumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTEYIIHWVKQKPGQGLEWIGSINPDYDITNYNQRFKGKATLTSDKSSRTAYMELSSLTSEDSAVYYCASWISDFFDYWGQGTSVTVSS
>Rontalizumab VL
DIVLTQSPASLAVSLGQRATISCRASQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVQEEDTATYYCQHSWGIPRTFGGGTKLEIK
>Rosmantuzumab VH
QVQLQQSGPELVKPGASVKISCKASGYTFTDYSIHWVKQRPGQGLEWIGYIYPSNGDSGYNQKFKNKATLTVDTSSSTAYMQLSSLTSEDSAVYFCATYFANNFDYWGQGTTLTVSS
>Rosmantuzumab VL
DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
>Rovalpituzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCARIGDSSPSDYWGQGTTLTVSS
>Rovalpituzumab VL
SIVMTQTPKFLLVSAGDRVTISCKASQSVSNDVVWYQQKPGQSPKLLIYYASNRYTGVPDRFTGSGYGTDFTFTISTVQAEDLAVYFCQQDYTSPWTFGGGTKLEIK
>Ruplizumab VH
QVQLKQSGAELVKPGASVKLSCKASGYTFTSYYMYWVKQRPGQGLEWIGEINPSNGDTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTRSDGRNDMDSWGQGTSVTVSS
>Ruplizumab VL
DIVLTQSPASLAVSLGLRATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVEEEDTATYYCQHSWEIPPTFGGGTKLEIK
>Sacituzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYTDDFKGRFAFSLETSVSTAYLQINNLKNEDTATYFCARGGFGSSYWYFDVWGAGSTVTVSS
>Sacituzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVSIAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFSGSGSGTDFTFTISSVQADDLAVYYCQQHYITPLTFGAGTKLEIK
>Samalizumab VH
QVQLQQTGPELVKPGASVKISCKASGYSFTDYIILWVKQNHGKSLEWIGHIDPYYGSSNYNLKFKGKATLTVDQSSSTAYMQLNSLTSEDSAVYYCGRSKRDYFDYWGQGTTLTVSS
>Samalizumab VL
DIQMTQSPSSLSASIGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGGGTKLEIK
>Sapelizumab VH
EVQLQESGPGLVKPSQSLSLTCTVTGHSITHDHAWSWIRQFPGEKLEWMGFISYSGITNYNPSLQGRISITRDTSKNQFFLQLNSVTTEDTATYYCARSLARTTAMDYWGEGTSVTVSS
>Sapelizumab VL
DIQMTQTTSSLSASLRDSVTISCQASTDISSHLNWYQQKPDGTVKLLIYYGSHLLSGVPSRFSGSGSGTDYSLTISNLEQEDAATYFCGQGNRLPYTFGGGTKLEIE
>Satralizumab VH
EVQLQESGPGLVKPSQSLSLTCTVTGHSITHDHAWSWIRQFPGEKLEWMGFISYSGITNYNPSLQGRISITRDTSKNQFFLQLNSVTTEDTATYYCARSLARTTAMDYWGEGTSVTVSS
>Satralizumab VL
DIQMTQTTSSLSASLRDSVTISCQASTDISSHLNWYQQKPDGTVKLLIYYGSHLLSGVPSRFSGSGSGTDYSLTISNLEQEDAATYFCGQGNRLPYTFGGGTKLEIE
>Simtuzumab VH
QVQLQQSGAELVRPGTSVKVSCKASGYAFTYYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSTSTAYMQLSSLTSEDTAVYFCARNWMNFDYWGQGSTLTVSS
>Simtuzumab VL
DIVMTQAAPSLPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCMQHLEYPYTFGGGTKLEIK
>Sofituzumab VH
EVQLKESGPGLVKPSQSLSLTCTVTGYSITNDYAWNWIRQFPGNKLEWMGYISYSGYTTYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARWTSGLDYWGQGTTLTVSS
>Sofituzumab VL
DIQMTQSSSSLSVSLGGRVTITCKASDLIHNWLAWYQQKPGNAPRLLISGATSLETGVPSRFSGSGSGEDYTLSIISLQTEDVATYYCQQYWTTPFTFGSGTKLEIK
>Solanezumab VH
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVSQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQLSSLKTEDTAIYYCARGDYWGQGTQVTVSS
>Solanezumab VL
DVVMTQSPLSLPVSLGDQTSISCRSSQSLIYSDGNAYLHWYLQKPGQSPELLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIK
>Spartalizumab VH
QVQLQQPGAELVKPGASVKLSCKASGYTFTTYWMHWVKQRPGQGLEWIGNIYPGTGGSNFDEKFKNKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRWTTGTGAYWGQGTLVTVSA
>Spartalizumab VL
DIVMTQSPSSLTVTPGEKVTLSCKSSQSLLDSGNQKNFLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDAAVYYCQNDYSYPYTFGGGTKLEIK
>Suvizumab VH
QVQLQQSGAELVRPGTSVKISCKASGYTFTNSWIGWVKQRPGHGLEWIGDIYPGGGYTNYNEIFKGKATLTADTSSSTAYMQLSSLTSEDSAVYFCSRGIPGYAMDYWGQGTSVTVSS
>Suvizumab VL
DIVMTQRPSSLSVSAGEKVTMSCKSSQSLLNSGDQKNYLTWYQQKPGQPPKLLIYWASTGESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPWTFGGGTKLEIK
>Tadocizumab VH
QVQLKESGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVIYPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARRDGNYGWFAYWGQGTLVTVSA
>Tadocizumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDINNYLNWYQQKPDGTVKLLIYYTSTLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEVK
>Talacotuzumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTDYYMKWAKQSHGKSLEWIGDIIPSNGATFYNQKFKGKATLTVDKSSSTTYMQLDSLTSEDSAVYYCARSHLLRASWFAYWGQGTLVTVSA
>Talacotuzumab VL
DIVMTQSPSSLAVSAGEKVTMSCESSQSLLNSGNQKNYLTWYQQKPGQPPKPLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPYTFGGGTKLEIK
>Tanezumab VH
QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYDLNWVRQPPGKGLEWLGIIWGDGTTDYNSAVKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARGGYWYATSYYFDYWGQGTTLTVSS
>Tanezumab VL
DIQMTQTTSSLSASLGDRVTISCRASQSISNNLNWYQQKPDGTVKLLIYYTSRFHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQEHTLPYTFGGGTKLEIK
>Telisotuzumab VH
QVQLQQSGPELVKPGASVKISCKTSGYTFTAYTMHWVKQSHGKSLEWIGWIKPNNGLANYAQKFQGKATLTVDKSSSTAYMELLSLTSEDSAVYYCARSEITTEFDYWGQGTTLTVSS
>Telisotuzumab VL
DIVLTQSPASLAVSLGQRATISCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGIPARFSGSGSRTDFTLTINPVEADDVATYYCQQSKEDPLTFGAGTKLELK
>Teplizumab VH
QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKVKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTPVTVSS
>Teplizumab VL
DIVMTQSTSSLSVSAGEKVTITCSASSSVSYMNWYQQTSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPFTFGSGTKLQIT
>Tibulizumab VH
QVQLQESGPGLVKPSETLSLTCAVSGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISTDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGVLVTVSS
>Tibulizumab VL
QIVLTQSPATMSASPGEKVTLTCRASQSVSRYLAWYQQKPGSSPKLRIYDASNRATGVPARFSGSGSGTSSSLTISSMEAEDAASYFCQQRSNWPRTFGGGTKLEIK
>Tigatuzumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYVMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARRGDSMITTDYWGQGTTLTVSS
>Tigatuzumab VL
DIVMTQSPKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYRTFGGGTKLEIK
>Tildrakizumab VH
QVQLQQSGPELVRPGASVKLSCKASGYIFITYWMTWVKQRPGQGLEWIGQIFPASGSADYNEKFEGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGGGFAYWGQGTLVTVSA
>Tildrakizumab VL
DIQMTQSPASLSAFVGETVTITCRTSENIYSYLAWYQQKQGKSPQFLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGIPFTFGSGTKLEIK
>Timigutuzumab VH
EVKLMESGAELVKPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYADSVKGKATITADTSSNTAYLQLSSLTSEDTAVYYCSRWGGDGFYAMDYWGQGTSVTVSS
>Timigutuzumab VL
DIMMTQSHKFMSTSVGDRVSITCRASQDVNTAVAWYQQKPGHSPKLLIYSASFLYSGVPDRFTGSRSGTDFTFTINSVQAEDLAVYYCQQHYTTPPTFGGGTKLEIK
>Tislelizumab VH
QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIYADGSTNYNPSLKSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARAYGNYWYIDVWGAGTTVTVSS
>Tislelizumab VL
SIVMTQTPKFLLVSAGDRVTITCKSSESVSNDVAWYQQKPGQSPKLLINYAFHRFTGVPDRFTGSGYGTDFTFTISTVQAEDLAVYFCHQAYSSPYTFGGGTKLEIK
>Tocilizumab VH
EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDHAWSWIRQFPGNKLEWMGYISYSGITTYNPSLKSRISILRDTSKNQFFLQLNSVTTEDTATYYCARSLARTTAMDYWGQGSSVTVSS
>Tocilizumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISSYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEIK
>Trastuzumab VH
EVKLMESGAELVKPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYADSVKGKATITADTSSNTAYLQLSSLTSEDTAVYYCSRWGGDGFYAMDYWGQGTSVTVSS
>Trastuzumab VL
DIMMTQSHKFMSTSVGDRVSITCRASQDVNTAVAWYQQKPGHSPKLLIYSASFLYSGVPDRFTGSRSGTDFTFTINSVQAEDLAVYYCQQHYTTPPTFGGGTKLEIK
>Tregalizumab VH
EEQLVETGGGLVRPGNSLKLSCVTSGFTFSDCRMYWLRQPPGKRLEWIAVISVKSENYGANYAESVRGRFTISRDDSKSSVYLQMNRLREEDTATYYCSASYYRYDVGAWFAYWGQGTLVTVSA
>Tregalizumab VL
DIVLTQSPDSLAVSLGQRATISCRASKSVSTSGYSYIYWYQQKPGQPPKLLIYLASILESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPWTFGGGTKLEIK
>Vandortuzumab VH
EVQLKESGPGLVKPSQSLSLTCTVSGYSITSDYAWNWIRQFPGNKLEWMGYISNSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARERNYDYDDYYYAMDYWGQGTSVTVSS
>Vandortuzumab VL
DIVMTQSPSSLAMSVGQKVTMSCKSSQSLLYRSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYNYPRTFGGGTKLEIK
>Vatelizumab VH
QVQLQESGPGLVAPSQSLSITCTVSGFSLTNYGIHWVRQPPGKGLEWLGVIWARGFTNYNSALMSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARANDGVYYAMDYWGQGTSVTVSS
>Vatelizumab VL
DFVMTQSPAIMSASPGEKVTITCSAQSSVNYIHWYQQKSDTSPKKWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWTTNPLTFGAGTKLELK
>Vedolizumab VH
QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGEIDPSESNTNYNQKFKGKATLTVDISSSTAYMQLSSLTSEDSAVYYCARGGYDGWDYAIDYWGQGTSVTVSS
>Vedolizumab VL
DVVVTQTPLSLPVSFGDQVSISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISTIKPEDLGMYYCLQGTHQPYTFGGGTKLEIK
>Veltuzumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAFYYCARSTYYGGDWYFDVWGAGTTVTVSS
>Veltuzumab VL
DIVLTQSPAILSASPGEKVTMTCRASSSVSYIHWYQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWTSNPPTFGGGTKLEIK
>Visilizumab VH
QVQLQQSGAELAKPGASVKLSCKASGYTFTSYTMHWVKQRPGQGLEWIGYINPRSGYTHYNQKLKDKATLTADKSSSTAYMQLSSLTYEDSAVYYCARSAYYDYDGFAYWGQGTLVTVSA
>Visilizumab VL
DIVLTQTPSSLSASLGDRVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPPTFGGGTKLEIK
>Vonlerolizumab VH
ELQLKESGPELVEPGASMKMSCKASGYTFTDSYMSGVRQSHGKSLEWIGDMYPDNGDSSYNQKFREKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVLAPRWYFSVWGAGTTVTVSS
>Vonlerolizumab VL
DIQMTQTPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLRSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGHTLPPTFGGGTKLEIK
>Vorsetuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADAFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARDYGDYGMDYWGQGTSVTVSS
>Vorsetuzumab VL
DIVLTQSPDSLAVSLGQRATISCRASKSVSTSGYSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSREVPWTFGGGTKLEIK
>Vunakizumab VH
EVQVVESGAELVRPGASVTLSCKASGYTFTDYEVHWVKQTPVHGLEWIGVIDPGTGGVAYNQKFEGKAILTADKSSSPAYLELRSLTSEDSAVYYCTRYSLFYGSSPYAMDYWGQGTSVTVSS
>Vunakizumab VL
EIVITQTTAIQSASPKEKVTITCSASSSVNYMHWYQQKSDASPKPWIYRTSNLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPWTFGGGTKLEIK
>Zenocutuzumab VH
EVQLQQSGPELVKPGASVKISCKASGYTFTGYYMHWVKQSHGKSLEWIGWINPNSGGTNYAQKFQGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARDHGSRHFWSYWGFDYWGTGTTVTVSS
>Zenocutuzumab VL
DIVLTQSPATLSVTPGDRVSLSCRASQSISSYLNWYQQKSHESPRLLIKAASSLQSGIPSRFSGSGSGTDFTLSINSVETEDFGMYFCQQSYSTPPTFGAGTKLELK
